Life Interrupted
High school athlete Jessica Hayes was healthy, active and had no family history of blood disorders. Her sudden-onset diagnosis of acquired hemophilia demonstrates the unpredictable nature of this rare and often life-threatening disease.
Leading with Diplomacy: Abbie Cornett
Abbie Cornett, chair and president of The Alliance for Biotherapeutics, advocates for patients who lack access to lifesaving therapies, have reimbursement restrictions and/or are denied coverage.
IG: The Challenge, the Promise, the Future
In the world of immune globulin, the demonstrated potential of these miraculous proteins to save and sustain lives is often thwarted by the complex and intertwined encumbrances that continually create barriers to access.
The Heart of the Matter
After being misdiagnosed with indigestion, Carolyn Thomas lived to tell what it’s like to be a heart attack survivor. Her mission? To help other women foil this all-too-common killer.
Back to the Future
In this issue of BioSupply Trends Quarterly, we honor the past as we look to an exciting future where once-prominent diseases will continue to be minimized or even eradicated.
Regaining Quality of Life
A rare neuromuscular disease left once-active senior Thelma Christison too weak to get out of bed. But intravenous immune globulin has helped her to significantly recover
Vaccines Past, Present and Future
BSTQ talks vaccine news and updates, and explores new uses for this life-saving technology.
Overcoming Antibiotic Resistance
Once considered a “super drug,” antibiotics are becoming increasingly ineffective against a host of new “super bugs.” Retiree Betty Gordon provides a glimpse into what it’s like to live with a growing list of relentless infections.
Envisioning a Vibrant Vaccine Industry: Damian A. Braga
With more than two decades of leadership in the vaccine industry, Damian A. Braga talks leadership, passion for public health and vision for the future.
Early-Onset Alzheimer’s: Holding Out Hope
If you think Alzheimer’s disease affects only the very elderly, think again. Early-onset Alzheimer’s can strike in midlife, with devastating consequences. But hope is on the horizon.